Patent Settlements in the Pharmaceutical Industry: What Can We Learn From Economic Analysis?
Patent settlements between originator and generic firms in the pharmaceutical industry have been challenged by antitrust and competition authorities in the U.S. and the EU. Particularly settlementswith large "reverse payments" to generic firms raise the concern of collusive behaviour for p...
Furkejuvvon:
| Publikašuvnnas: | MAGKS - Joint Discussion Paper Series in Economics (Band 01-2016) |
|---|---|
| Váldodahkkit: | , |
| Materiálatiipa: | Artihkal |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Philipps-Universität Marburg
2015
|
| Fáttát: | |
| Liŋkkat: | PDF-ollesdeaksta |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
No citations were found for this record.